BAYZF - German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal Trial Setbacks | Benzinga
Bayer AG (OTC: BAYRY) (OTC: BAYZF) reportedly held an investor call to address concerns after intense scrutiny from investors following a series of unforeseen setbacks, prompting questions about transparency surrounding its recent $5.75 billion bond issuance.
The company encountered a cascade of issues, including a major setback in a late-stage anti-clotting drug trial that led to Full story available on Benzinga.com